Researchers reveal the vulnerability of large language models in medicine.
Gilead renews IT contract with Cognizant in bid to more quickly bring drugs to market
Gilead is expanding and renewing an IT contract with Cognizant that is now worth up to $800 million over five years. Cognizant said Monday that